Showing results (11-20 of 37) with videos related to
Sort By:
Pageof 4
Biorxiv : the Preprint Server for Biology|November 28, 2023
Molecular determinants of antagonist interactions with chemokine receptors CCR2 and CCR5John R D Dawson, Grant M Wadman, Penglie Zhang, et al.The Journal of Experimental Medicine|February 9, 2011
CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunityLillian Cruz-Orengo, David W Holman, Denise Dorsey, et al.Blood|May 24, 2012
CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone diseaseDaniel J Dairaghi, Babatunde O Oyajobi, Anjana Gupta, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2017
IL-17-Secreting γδ T Cells Are Completely Dependent upon CCR6 for Homing to Inflamed SkinJames J Campbell, Karen Ebsworth, Linda S Ertl, et al.Science Advances|July 20, 2022
Structures of atypical chemokine receptor 3 reveal the basis for its promiscuity and signaling biasYu-Chen Yen, Christopher T Schafer, Martin Gustavsson, et al.Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Design, synthesis, and SAR of anthranilamide-based factor Xa inhibitors with improved functional activityPenglie Zhang, Liang Bao, Jingmei F Zuckett, et al.Bioorganic & Medicinal Chemistry Letters|February 5, 2013
1-(4-Phenylpiperazin-1-yl)-2-(1H-pyrazol-1-yl)ethanones as novel CCR1 antagonistsAndrew M K Pennell, James B Aggen, Subhabrata Sen, et al.Bioorganic & Medicinal Chemistry Letters|February 26, 2004
1-(2-Naphthyl)-1H-pyrazole-5-carboxylamides as potent factor Xa inhibitors. Part 2: A survey of P4 motifsZhaozhong J Jia, Yanhong Wu, Wenrong Huang, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 31, 2009
Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligandsBrian A Zabel, Yu Wang, Susanna Lewén, et al.Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Design, synthesis, and SAR of anthranilamide-based factor Xa inhibitors incorporating substituted biphenyl P4 motifsPenglie Zhang, Liang Bao, Jingmei F Zuckett, et al.Pageof 4